Monday, October 06, 2014 4:44:30 PM
VVVVVVVV
VVVVVVV
VVVVVV
VVVVV
VVVV
VVV
VV
V
Article on Seeking Alpha.
ByPoonam A. Arora:
Investment Conclusion. This week, Puma Biotechnology (NYSE:PBYI) reported data from its ExteNET study on Neratinib in the adjuvant setting as 2nd year treatment following a full year of Herceptin therapy for HER2+ breast cancer. The data indicated 33% and 37% improvement over placebo for the overall and subgroup populations. However, the read out was missing DFS figures required to reach any conclusions on the strength of the results. In addition, in the HERA study that evaluated Herceptin as 2nd year treatment following a 1st full year of the drug, the DFS at 3 years follow up approached 89%. Therefore, Neratinib would have to handily beat that statistic for payors to reimburse the drug after a full year of Herceptin, particularly because the HERA study showed no benefit of 2nd year treatment with Herceptin following 1 year with the drug.
Recent PBYI News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 01:01:05 PM
- Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference • Business Wire • 09/03/2024 08:15:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/27/2024 09:02:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 01:00:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 01:00:09 PM
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/06/2024 09:23:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:41:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:17:49 PM
- Puma Biotechnology Reports Second Quarter Financial Results • Business Wire • 08/01/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2024 11:11:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2024 11:06:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2024 10:57:18 PM
- Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results • Business Wire • 07/18/2024 08:10:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/18/2024 12:43:05 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/18/2024 12:39:26 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/18/2024 12:36:50 AM
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 07/02/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:27:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:25:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:23:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:18:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/14/2024 01:46:47 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/14/2024 01:44:55 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/14/2024 01:43:51 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/14/2024 01:41:17 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM